File: /home/govancoz/mail/new/1758785085.M845105P1374758.zacp120.webway.host,S=8932,W=9037
Return-Path: <recruitment.ho@goyalgroup.net.in>
Delivered-To: govancoz@zacp120.webway.host
Received: from zacp120.webway.host
by zacp120.webway.host with LMTP
id yIRzMD3u1Ggm+hQA8rC0kQ
(envelope-from <recruitment.ho@goyalgroup.net.in>)
for <govancoz@zacp120.webway.host>; Thu, 25 Sep 2025 09:24:45 +0200
Return-path: <recruitment.ho@goyalgroup.net.in>
Envelope-to: candice@govan.co.za
Delivery-date: Thu, 25 Sep 2025 09:24:45 +0200
Received: from host2.dressupkit.com ([67.225.158.12]:46690)
by zacp120.webway.host with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.98.2)
(envelope-from <recruitment.ho@goyalgroup.net.in>)
id 1v1gLL-000000062VH-2m2A
for candice@govan.co.za;
Thu, 25 Sep 2025 09:24:45 +0200
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/relaxed;
d=goyalgroup.net.in; s=default; h=Reply-To:Date:From:To:Subject:MIME-Version:
Content-Type:Sender:Message-ID:Cc:Content-Transfer-Encoding:Content-ID:
Content-Description:Resent-Date:Resent-From:Resent-Sender:Resent-To:Resent-Cc
:Resent-Message-ID:In-Reply-To:References:List-Id:List-Help:List-Unsubscribe:
List-Subscribe:List-Post:List-Owner:List-Archive;
bh=BpJryvPkwonpDrlN+cWaoQTLEP/+Fhgjyrj8tgkf/c8=; b=ayHfaxHwzd0JDTXepTZZ7jbvuI
u1V4KgPXTXscuunEbpFAFaBDv4igb/InjN5xNDQlC1KpCuRun1YynGEG3mEvUE6lU3g5BQxX05r3/
rIXSgUMCKkg60PYP4Xron653uiuR4tAWiSMeGusfQV/Tx3CrZ5TDKp6cZ9giUv2j5omLbVmwOSVKL
4hItRaxkEITbpJ+nat/fpPv+CpTQizGJWD7niEbyfAyzn0eYKTXpWBz3/D/ch5qLaXmPtpsMmBdi8
Fo/Kdq3M/4cOLkFfsU8m7aQ3KTLnkyf6I7HpXrA/khVuSmE+a1SK+Z/4gAlKM4vSMDqI7jdc0sG8Z
6mvslzQw==;
Received: from c155-179.i01-7.onvol.net ([212.56.155.179]:54900 helo=ws-dip-gc02.diplomat.com.mt)
by host.gamesbunch.com with esmtpa (Exim 4.98.1)
(envelope-from <recruitment.ho@goyalgroup.net.in>)
id 1v0xYw-000000000lM-2aai;
Tue, 23 Sep 2025 13:05:45 +0530
Content-Type: multipart/alternative; boundary="===============1741029001=="
MIME-Version: 1.0
Subject: Proposal for Strategic Business Collaboration.
To: Recipients <recruitment.ho@goyalgroup.net.in>
From: "Dr. Shingo Iwamoto" <recruitment.ho@goyalgroup.net.in>
Date: Tue, 23 Sep 2025 09:34:49 +0200
Reply-To: drshingoiwamotopharm1@gmail.com
X-AntiAbuse: This header was added to track abuse, please include it with any abuse report
X-AntiAbuse: Primary Hostname - host.gamesbunch.com
X-AntiAbuse: Original Domain - govan.co.za
X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12]
X-AntiAbuse: Sender Address Domain - goyalgroup.net.in
X-Get-Message-Sender-Via: host.gamesbunch.com: authenticated_id: recruitment.ho@goyalgroup.net.in
X-Authenticated-Sender: host.gamesbunch.com: recruitment.ho@goyalgroup.net.in
X-Source:
X-Source-Args:
X-Source-Dir:
X-Spam-Status: No, score=1.8
X-Spam-Score: 18
X-Spam-Bar: +
X-Ham-Report: =?ISO-8859-1?Q?Spam_detection_software=2C_running_on_the_system_=22zacp120=2Ewebway?= =?ISO-8859-1?Q?=2Ehost=22=2C=0A_has_NOT_identified_this_incoming_ema?= =?ISO-8859-1?Q?il_as_spam=2E__The_original=0A_message_has_been_attac?= =?ISO-8859-1?Q?hed_to_this_so_you_can_view_it_or_label=0A_similar_fu?= =?ISO-8859-1?Q?ture_email=2E__If_you_have_any_questions=2C_see=0A_ro?= =?ISO-8859-1?Q?ot=5C=40localhost_for_details=2E=0A_Content_preview=3A_?= =?ISO-8859-1?Q?_Dear_Esteemed_Professional=2C_I_hope_this_message_fi?= =?ISO-8859-1?Q?nds_you=0A___well=2E_Nichi-Iko_Pharmaceutical_Co=2E=2C?= =?ISO-8859-1?Q?_Ltd=2E=2C_a_leading_pharmaceutical_manufacturer=0A__?= =?ISO-8859-1?Q?__based_in_Japan=2C_is_currently_seeking_a_qualified_?= =?ISO-8859-1?Q?individual_to_=5B=2E=2E=2E=5D_=0A_Content_analysis_de?= =?ISO-8859-1?Q?tails=3A___=281=2E8_points=2C_5=2E0_required=29=0A__p?= =?ISO-8859-1?Q?ts_rule_name______________description=0A_----_-------?= =?ISO-8859-1?Q?---------------_-------------------------------------?= =?ISO-8859-1?Q?-------------=0A__0=2E0_RCVD=5FIN=5FVALIDITY=5FCERTIF?= =?ISO-8859-1?Q?IED=5FBLOCKED_RBL=3A_ADMINISTRATOR_NOTICE=3A_The=0A__?= =?ISO-8859-1?Q?___________________________query_to_Validity_was_bloc?= =?ISO-8859-1?Q?ked=2E__See=0A_____________________________https=3A//?= =?ISO-8859-1?Q?knowledge=2Evalidity=2Ecom/hc/en-us/articles/20961730?= =?ISO-8859-1?Q?681243=0A______________________________for_more_infor?= =?ISO-8859-1?Q?mation=2E=0A__________________________=5B67=2E225=2E1?= =?ISO-8859-1?Q?58=2E12_listed_in_sa-trusted=2Ebondedsender=2Eorg=5D=0A?= =?ISO-8859-1?Q?__0=2E0_RCVD=5FIN=5FVALIDITY=5FRPBL=5FBLOCKED_RBL=3A_?= =?ISO-8859-1?Q?ADMINISTRATOR_NOTICE=3A_The_query_to=0A______________?= =?ISO-8859-1?Q?________________Validity_was_blocked=2E__See=0A______?= =?ISO-8859-1?Q?_______________________https=3A//knowledge=2Evalidity?= =?ISO-8859-1?Q?=2Ecom/hc/en-us/articles/20961730681243=0A___________?= =?ISO-8859-1?Q?___________________for_more_information=2E=0A________?= =?ISO-8859-1?Q?_____________________=5B67=2E225=2E158=2E12_listed_in?= =?ISO-8859-1?Q?_bl=2Escore=2Esenderscore=2Ecom=5D=0A__0=2E0_RCVD=5FI?= =?ISO-8859-1?Q?N=5FVALIDITY=5FSAFE=5FBLOCKED_RBL=3A_ADMINISTRATOR_NO?= =?ISO-8859-1?Q?TICE=3A_The_query_to=0A______________________________?= =?ISO-8859-1?Q?Validity_was_blocked=2E__See=0A______________________?= =?ISO-8859-1?Q?_______https=3A//knowledge=2Evalidity=2Ecom/hc/en-us/?= =?ISO-8859-1?Q?articles/20961730681243=0A___________________________?= =?ISO-8859-1?Q?___for_more_information=2E=0A________________________?= =?ISO-8859-1?Q?_____=5B67=2E225=2E158=2E12_listed_in_sa-accredit=2Eh?= =?ISO-8859-1?Q?abeas=2Ecom=5D=0A_-0=2E0_SPF=5FPASS_______________SPF?= =?ISO-8859-1?Q?=3A_sender_matches_SPF_record=0A_-0=2E1_DKIM=5FVALID=5FA?= =?ISO-8859-1?Q?U__________Message_has_a_valid_DKIM_or_DK_signature_f?= =?ISO-8859-1?Q?rom_author's=0A_____________________________domain=0A_?= =?ISO-8859-1?Q?-0=2E1_DKIM=5FVALID_____________Message_has_at_least_?= =?ISO-8859-1?Q?one_valid_DKIM_or_DK_signature=0A__0=2E1_DKIM=5FSIGNE?= =?ISO-8859-1?Q?D____________Message_has_a_DKIM_or_DK_signature=2C_no?= =?ISO-8859-1?Q?t_necessarily_valid=0A_-0=2E1_DKIM=5FVALID=5FEF______?= =?ISO-8859-1?Q?____Message_has_a_valid_DKIM_or_DK_signature_from=0A_?= =?ISO-8859-1?Q?____________________________envelope-from_domain=0A__?= =?ISO-8859-1?Q?0=2E2_FREEMAIL=5FREPLYTO=5FEND=5FDIGIT_Reply-To_freem?= =?ISO-8859-1?Q?ail_username_ends_in_digit=0A________________________?= =?ISO-8859-1?Q?_____=5Bdrshingoiwamotopharm1=28at=29gmail=2Ecom=5D=0A?= =?ISO-8859-1?Q?__0=2E0_HTML=5FMESSAGE___________BODY=3A_HTML_include?= =?ISO-8859-1?Q?d_in_message=0A__1=2E8_FREEMAIL=5FFORGED=5FREPLYTO_Fr?= =?ISO-8859-1?Q?eemail_in_Reply-To=2C_but_not_From?=
X-Spam-Flag: NO
You will not see this in a MIME-aware mail reader.
--===============1741029001==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Dear Esteemed Professional,
I hope this message finds you well.
Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer =
based in Japan, is currently seeking a qualified individual to serve as our=
official representative in South Africa. This role involves managing miner=
al procurement and overseeing the establishment of our annex office in Sout=
h Africa under a five-year contractual agreement.
This is a strategic opportunity to represent a respected global brand and =
play a key role in expanding our international presence. We are offering a =
competitive compensation package along with decision-making autonomy.
If you are interested in learning more, kindly respond to this message for=
further details.
Warm regards,
Dr. Shingo Iwamoto
President & CEO
Nichi-Iko Pharmaceutical Co., Ltd.
5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan
--===============1741029001==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Dear Esteemed Professional,</P>
<P>I hope this message finds you well.</P>
<P>Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacture=
r based in Japan, is currently seeking a qualified individual to serve as o=
ur official representative in South Africa. This role involves managing min=
eral procurement and overseeing the establishment of our annex office in So=
uth Africa under a five-year contractual agreement.</P>
<P>This is a strategic opportunity to represent a respected global brand an=
d play a key role in expanding our international presence. We are offering =
a competitive compensation package along with decision-making autonomy.</P>
<P>If you are interested in learning more, kindly respond to this message f=
or further details.</P>
<P>Warm regards,<BR>Dr. Shingo Iwamoto<BR>President & CEO<BR>Nichi-Iko =
Pharmaceutical Co., Ltd.<BR>5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, =
Japan</P></BODY></HTML>
--===============1741029001==--